Allergy Therapeutics announces positive new clinic data with house-dust mite immunotherapy

Allergy Therapeutics plc (LON:AGY) said that house-dust immunotherapy has shown to be well-tolerated and demonstrates highly significant symptom … … (continue)

See more: